The hyperthermia cancer treatment market is a relatively small but quickly growing subsegment of oncology, based on the application of heat to malignancies. This form of treatment is also known as fever therapy and takes benefit of heating tumor tissue to affect the cancer cells, and as a result exposes it to higher temperatures that increases its sensitivity to radiation treatment and chemotherapy. The aim of this treatment is to increase the potency of radiation therapy and chemotherapy making the tumor tissues better supplied with blood and oxygen. They are based on the principle of generating heat of controlled intensiveness that is lethal to cancer cells and causes their apoptosis and at the same time sparing the healthy cells.

It can therefore be defined as a subsector of the health care sector that comprises a numerous product as well as services within immunology and other related ailments. The immunology market can thus be defined as one of the segments of the healthcare industry that embraces many of the products as well as services related to immunology and other diseases or conditions mentioned above.

Haemostat Market Size Was Valued at USD 4.75 Billion in 2023, and is Projected to Reach USD 9.33 Billion by 2032, Growing at a CAGR of 7.9% From 2024-2032.

The treatment of healthcare interventional pulmonology is a rather narrow segment of medical practice that involves the diagnosis and subsequent treatment of diseases that affect people’s lungs with the help of minimally invasive techniques.